Showing results (381-390 of 1,349) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|February 14, 2022
Bioequivalence and Safety of Levetiracetam Granules and Oral Solution: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Chinese Volunteers Under a Fasting ConditionYun Liu, Yang Zou, Yijun Wang, et al.
Clinical Pharmacology in Drug Development|February 17, 2022
Single-Dose Pharmacokinetics and Safety of Ubrogepant in Adults With Hepatic Impairment: Results From an Open-Label, Phase 1 TrialRamesh Boinpally, Kaifeng Lu
Clinical Pharmacology in Drug Development|March 22, 2022
Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed-Release and Extended-Release Methylphenidate: In Vivo, In Vitro, and Modeling EvaluationsBev Incledon, Chantal Incledon, Roberto Gomeni, et al.
Clinical Pharmacology in Drug Development|September 20, 2018
Pharmacokinetics, Excretion, and Mass Balance of [14 C]-Batefenterol Following a Single Microtracer Intravenous Dose (Concomitant to an Inhaled Dose) or Oral Dose of Batefenterol in Healthy MenClaire Ambery, Graeme Young, Teresa Fuller, et al.
Clinical Pharmacology in Drug Development|August 30, 2018
Pharmacokinetics, Safety, and Tolerability of the Dual Inhibitor of Tumor Necrosis Factor-α and Interleukin 17A, ABBV-257, in Healthy Volunteers and Patients With Rheumatoid ArthritisAhmed A Othman, Amit Khatri, Ralf Loebbert, et al.
Clinical Pharmacology in Drug Development|June 16, 2018
Pharmacokinetics, Safety, and Tolerability of Rolapitant Administered Intravenously Following Single Ascending and Multiple Ascending Doses in Healthy SubjectsXiaodong Wang, Zhi-Yi Zhang, Jing Wang, et al.
Clinical Pharmacology in Drug Development|May 26, 2018
Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid TumorsGeoffrey I Shapiro, Rebecca S Kristeleit, Howard A Burris, et al.
Clinical Pharmacology in Drug Development|June 6, 2018
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug-Drug Interaction Studies in Healthy SubjectsMendel Jansen, Jeanne Mendell, Alexander Currie, et al.
Clinical Pharmacology in Drug Development|May 4, 2018
Pharmacokinetic and Pharmacodynamic Correlations From 2 Studies Evaluating Abuse Potential of Hydrocodone Extended-Release TabletsKerri A Schoedel, Michael Gillespie, Naama Levy-Cooperman, et al.
Clinical Pharmacology in Drug Development|September 6, 2025
Phenobarbital Bioequivalence in Chinese Population: Considering the Role of Food on PharmacokineticsWang Xinman, Liu Yuan, Sun Ying, et al.
Pageof 135